Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes - Pitt, Bertram; Filippatos, Gerasimos; Agarwal, Rajiv; Anker, Stefan D; Bakris, George L; Rossing, Peter; Joseph, Amer; Kolkhof, Peter; Nowack, Christina; Schloemer, Patrick; Ruilope, Luis M (The New England journal of medicine, 2021)
Keywords: Adverse events; Aged; Albumin; Albuminuria - etiology; Angiotensin; Cardiology; Cardiology General; Cardiovascular Diseases - epidemiology; Cardiovascular Diseases - mortality; Cardiovascular Diseases - prevention & control; Cerebral infarction; Chronic Kidney Disease; Clinical medicine; Congestive heart failure; Creatinine; Design; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Double-Blind Method; Endocrinology; Epidermal growth factor receptors; Female; Glomerular filtration rate; Heart failure; Hospitalization; Humans; Hyperkalemia; Kidney diseases; Male; Middle Aged; Mineralocorticoid Receptor Antagonists - adverse effects; Mineralocorticoid Receptor Antagonists - therapeutic use; Myocardial infarction; Naphthyridines - adverse effects; Naphthyridines - therapeutic use; Nephrology; Patient safety; Placebos; Potassium; Proportional Hazards Models; Renal failure; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - drug therapy; Renin